Herlev University Hospital Treats First Patient in Denmark on Varian Halcyon System
Palo Alto, Calif. and Herlev, Denmark, June 10, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced Herlev University Hospital near Copenhagen, Denmark is Scandinavia's first facility to utilize the Halcyon™ system. The first patient treated on the system was a 42-year-old female undergoing treatment for anal cancer. Halcyon simplifies and enhances virtually every aspect of image-guided volumetric intensity-modulated radiotherapy (IMRT), including improved patient...This story is related to the following:Medical Equipment Machinery
Conclusions The mildly invasive nature of DARE, limited likelihood of adverse procedure-related events, cost-effectiveness and patient acceptability, as well as wide availability of DARE support consideration of its integration into screening for populations at high risk of anal cancer, especially HIV-positive men who have sex with men.
Conclusions: Most participating women considered anal cancer screening necessary and very acceptable. Longer screening intervals and adequate pain management could further increase the acceptability of repeated screening. PMID: 32218656 [PubMed - as supplied by publisher]
This article discusses the most commonly encountered anal canal tumors, the evaluation of these tumors, and their management. The foundation for successful therapy includes timely diagnosis, accurate staging, and routine surveillance.
ConclusionsFDG PET/CT performed at staging has a good diagnostic performance in anal cancer patients. Some baseline metabolic parameters seem to have also a prognostic significance. Further research is required to validate these results.
Conclusions: This case underscores the importance of recognizing the emerging role of these rare “possibly carcinogenic” HPV types in human carcinogenesis.
ANAL cancer is a rare form of the disease that affects the end of the bowel. What are the five signs of the deadly disease you need to know about?
ConclusionOur study showed an excellent clinical result and very low acute toxicity rates, confirming the IMRT as standard of care for curative treatment of anal cancer patients.The current trial was registered with the number IEO N87/11
Asian men with HIV are much less likely than their white peers to have discussed anal-cancer screening with a healthcare provider, new findings from Canada show.Reuters Health Information
A prone treatment setup is used by some institutions for treatment of breast, rectal, and anal cancer, for enhanced normal tissue sparing, specifically lower doses to heart, lung, and bowel. However, many have reported that a supine orientation demonstrates better setup reproducibility. Radiotherapy for head and neck cancers (HNC) is typically delivered with the patient in supine position due to reproducibility and comfort, with a thermoplastic mass for head and shoulder immobilization. It is not uncommon, however, to have a patient who cannot tolerate this position because of pooling of secretions, which can lead to aspir...
CONCLUSION: The survival rate for anal cancer in Korea has improved steadily over time. The characteristics related to survival were the histological type, sex, and age. These statistics will be fundamental for future Korean anal cancer research. PMID: 32146787 [PubMed]